Epidermal Growth Factor (EGFR) is almost systematically overexpressed in HNSCC, but no clear correlation has been established between EGFR expression levels and individual response to cetuximab [6]. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.